Delayed maculopapular, urticarial rash due to infliximab in two children with systemic onset juvenile idiopathic arthritis [6]

Rheumatology

Volumn 43, Issue 5, 2004, Pages 674-675

  Tutar, E ^a   Ekici, F ^a   Nacar N ^a   Arici, S ^a   Atalay, S ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADOLESCENT; CASE REPORT; CONJUNCTIVITIS; DRUG ERUPTION; FEMALE; FEVER; GINGIVITIS; GROWTH RETARDATION; HERPES; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; JUVENILE RHEUMATOID ARTHRITIS; LETTER; MALE; MOUTH INFECTION; OSTEOPOROSIS; PAIN ASSESSMENT; PAPULAR URTICARIA; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; REMISSION; SCHOOL CHILD; SKIN BIOPSY; STOMATITIS; VISUAL ANALOG SCALE; WELLBEING;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; URTICARIA;

EID: 2442424048     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh142     Document Type: Letter

References (7)

1. Lahdenne P, Vähäsalo P, Honkanen V. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis 2003;62:245-7.
2. Billiau AD, Cornillie F, Wouters C. Infliximab for systemic onset juvenile idiopathic arthritis: experience in 3 children. J Rheumatol 2002;29:1111-4.
3. Fitzcharles M, Clayton D, Menard HA. The use of infliximab in academic rheumatology practice: an audit of early clinical experience. J Rheumatol 2002;29:2525-30.
4. Markham A, Lamb HM. Infliximab. A review of its use in the management of rheumatoid arthritis. Drugs 2000;59:1341-59.
5. Vergara G, Silvestre JF, Belloch I, Vela P, Albares MP, Pascual JC. Cutaneous drug eruption to infliximab: report of 4 cases with an interphase reaction. Arch Dermatol 2002;138:1258-9.
6. McCain ME, Quinet RJ, Davis WE. Etanercept and infliximab associated with cutaneous vasculitis. Rheumatology 2002;41:116-7.
7. Livermore P. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis. Rheumatology 2002;41:1450-2.